Voyager Therapeutics (NASDAQ: VYGR) affiliate files to sell 9,406 shares

Rhea-AI Filing Summary

Voyager Therapeutics (VYGR) notice of proposed sale of 9,406 shares of common stock under Section 144, with the transaction dated 05/15/2026. The filing notes an option granted on 02/06/2026 and lists 60,421,287 shares outstanding as of 05/15/2026 as a context figure. The record shows a prior sale of 4,668 shares on 02/24/2026 generating $17,588.09 in proceeds.

Insights

Securities Compliance Counsel

Form 144 reports a proposed registered resale of shares by an affiliate under Rule 144.

The filing lists 9,406 shares proposed for sale on 05/15/2026, tied to an option granted 02/06/2026. It also records a prior disposition of 4,668 shares on 02/24/2026.

Rule 144 notices are administrative disclosures; the actual sale depends on broker execution and compliance with holding‑period and public information requirements. Subsequent filings will show completion or further dispositions.

Key Figures

Proposed resale: 9,406 shares Prior sale: 4,668 shares Proceeds from prior sale: $17,588.09 +2 more

5 metrics

Proposed resale 9,406 shares proposed sale date 05/15/2026

Prior sale 4,668 shares sold on 02/24/2026 for $17,588.09

Proceeds from prior sale $17,588.09 proceeds from 02/24/2026 disposition

Shares outstanding 60,421,287 shares as of 05/15/2026

Option grant date 02/06/2026 option granting the shares to be sold

Key Terms

Form 144, Option Granted, Issuer

3 terms

Form 144 regulatory

"Common | Fidelity Brokerage Services LLC ... | 9406 | 05/15/2026"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Option Granted financial

"Securities To Be Sold ... Option Granted - 02/06/2026"

Issuer regulatory

"Securities To Be Sold ... Issuer ... 9406"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/15/2026 - 10:34 AM Learn about SEC filing dates

FAQ

What does the VYGR Form 144 report?

It reports a proposed sale of 9,406 common shares on 05/15/2026. The notice ties the sale to an option granted 02/06/2026 and records a prior sale of 4,668 shares on 02/24/2026 that produced $17,588.09 in proceeds.

Who is the likely broker handling the transaction for VYGR?

Fidelity Brokerage Services LLC is listed as the broker/dealer for the transaction. The filing shows the broker at 900 Salem Street, Smithfield, RI, associated with the 9,406 shares and the 05/15/2026 transaction date.

What prior sales are disclosed in the VYGR excerpt?

A prior sale of 4,668 common shares on 02/24/2026 is disclosed. That disposition generated $17,588.09 in proceeds and is presented alongside the proposed resale dated 05/15/2026 in the filing excerpt.

How many VYGR shares were outstanding per the filing?

The filing lists 60,421,287 shares outstanding as of 05/15/2026. This figure appears in the securities information block and serves as a context number in the excerpt provided.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	9406	39881.44	60421287	05/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/15/2026	Option Granted - 02/06/2026	Issuer			9406	05/15/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Nathan Jorgensen 75 Hayden Avenue Lexington MA 02421	Common	02/24/2026	4668	17588.09

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)